Kinaxis Inc. (TSE:KXS – Get Free Report) Senior Officer Vasile Gelu Ticala sold 3,534 shares of the stock in a transaction dated Friday, June 13th. The stock was sold at an average price of C$201.00, for a total transaction of C$710,334.00. Following the completion of the transaction, the insider now owns 596 shares of the company’s stock, valued at approximately C$119,796. The trade was a 85.57% decrease in their ownership of the stock.
Vasile Gelu Ticala also recently made the following trade(s):
- On Friday, June 13th, Vasile Gelu Ticala sold 2,000 shares of Kinaxis stock. The stock was sold at an average price of C$201.00, for a total transaction of C$402,000.00.
Kinaxis Stock Performance
Shares of TSE KXS opened at C$200.70 on Wednesday. The firm’s 50-day moving average price is C$189.52 and its 200-day moving average price is C$175.60. The company has a quick ratio of 2.29, a current ratio of 1.89 and a debt-to-equity ratio of 12.12. The company has a market cap of C$4.04 billion, a PE ratio of 199.19, a PEG ratio of 3.60 and a beta of 0.78. Kinaxis Inc. has a 52-week low of C$132.93 and a 52-week high of C$202.91.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Report on KXS
Kinaxis Company Profile
Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Europe, Asia, and Canada. It offers RapidResponse, a cloud-based platform, which provides advanced planning, sales and operation planning, supply and demand planning, inventory management, and command and control center services.
Featured Stories
- Five stocks we like better than Kinaxis
- Where Do I Find 52-Week Highs and Lows?
- Analyst Downgrades Joby, But Overlooks Major Regulatory Wins
- How to Invest in Blue Chip Stocks
- U.S. Steel Stock Burns the Bears With Surprise Upside Move
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Lululemon, UNH, Enphase: Bad News, Good Opportunity?
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.